NCT06495073 Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA
| NCT ID | NCT06495073 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2024-05-20 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2024-05-20 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patient-related outcome measures (PROMs) play a crucial role in assessing patient outcomes in healthcare. Two of these PROMs are the The Older Persons and Informal Caregivers Survey Short Form (TOPICS-SF) and Patient-Reported Outcomes Measurement Information System Global Health Short Form (PROMIS-10). The investigators aim to determine the Minimal Clinically Important Difference (MCID) for the TOPICS-SF and PROMIS-10 in older people that suffered an ischemic stroke or Transient Ischemic Attack (TIA), using an anchor-based method.
Eligibility Criteria
Inclusion Criteria: * age = 70 years or older at the time of ischemic stroke or TIA; * inclusion within a week after diagnosis of ischemic stroke or TIA Exclusion Criteria: * not speaking Dutch; * being unable to answer questions; * being unable or not willing to give written informed consent.
Contact & Investigator
Renske van den Berg-Vos, Prof, dr.
PRINCIPAL INVESTIGATOR
Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Frequently Asked Questions
Who can join the NCT06495073 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, up to 120 Years, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06495073 currently recruiting?
Yes, NCT06495073 is actively recruiting participants. Contact the research team at s.r.prins@amsterdamumc.nl for enrollment information.
Where is the NCT06495073 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Amsterdam, Netherlands.
Who is sponsoring the NCT06495073 clinical trial?
NCT06495073 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Renske van den Berg-Vos, Prof, dr. at Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.